Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   
X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

ROS1 (ROS proto-oncogene 1 , receptor tyrosine kinase)

Written2014-01Samuel J Klempner, Sai-Hong Ou
University of California Irvine Medical Center, Orange, CA. sklempne@uci.edu; siou@uci.edu

Abstract ROS1 is proto-oncogene encoding a type I integral membrane protein with receptor tyrosine kinase (RTK) activity. ROS1 is a member of the insulin receptor family and is involved in downstream signalling processes involved in cell growth and differentiation.

Keywords ROS1; tyrosine kinase; insulin receptor family; cell growth and differentiation; cancer

(Note : for Links provided by Atlas : click)

Identity

Alias_namesv-ros avian UR2 sarcoma virus oncogene homolog 1
v-ros UR2 sarcoma virus oncogene homolog 1 (avian)
c-ros oncogene 1 , receptor tyrosine kinase
Alias_symbol (synonym)MCF3
ROS
c-ros-1
Other alias
HGNC (Hugo) ROS1
LocusID (NCBI) 6098
Atlas_Id 42144
Location 6q22.1  [Link to chromosome band 6q22]
Location_base_pair Starts at 117288367 and ends at 117425855 bp from pter ( according to hg19-Feb_2009)  [Mapping ROS1.png]
Fusion genes
(updated 2017)		Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands)
ALK (2p23.2) / ROS1 (6q22.1)C10orf10 (10q11.21) / ROS1 (6q22.1)CCDC6 (10q21.2) / ROS1 (6q22.1)
CD74 (5q32) / ROS1 (6q22.1)CD74 (5q33.1) / ROS1 (6q22.1)CEP85L (6q22.31) / ROS1 (6q22.1)
CLIP1 (12q24.31) / ROS1 (6q22.1)CLTC (17q23.1) / ROS1 (6q22.1)ERC1 (12p13.33) / ROS1 (6q22.1)
EZR (6q25.3) / ROS1 (6q22.1)GOPC (6q22.1) / ROS1 (6q22.1)HLA-A (6p22.1) / ROS1 (6q22.1)
KDELR2 (7p22.1) / ROS1 (6q22.1)KMT2A (11q23.3) / ROS1 (6q22.1)LRIG3 (12q14.1) / ROS1 (6q22.1)
MYO5A (15q21.2) / ROS1 (6q22.1)PPFIBP1 (12p11.23) / ROS1 (6q22.1)PWWP2A (5q33.3) / ROS1 (6q22.1)
ROS1 (6q22.1) / CCDC6 (10q21.2)ROS1 (6q22.1) / CD74 (5q32)ROS1 (6q22.1) / CD74 (5q33.1)
ROS1 (6q22.1) / EZR (6q25.3)ROS1 (6q22.1) / GOPC (6q22.1)ROS1 (6q22.1) / LRIG3 (12q14.1)
ROS1 (6q22.1) / SDC4 (20q13.12)ROS1 (6q22.1) / SLC34A2 (4p15.2)SDC4 (20q13.12) / ROS1 (6q22.1)
SHTN1 (10q25.3) / ROS1 (6q22.1)SLC34A2 (4p15.2) / ROS1 (6q22.1)TFG (3q12.2) / ROS1 (6q22.1)
TPM3 (1q21.3) / ROS1 (6q22.1)YWHAE (17p13.3) / ROS1 (6q22.1)ZCCHC8 (12q24.31) / ROS1 (6q22.1)
Note ROS1 is proto-oncogene encoding a type I integral membrane protein with receptor tyrosine kinase (RTK) activity. ROS1 is a member of the insulin receptor family and is involved in downstream signalling processes involved in cell growth and differentiation.

DNA/RNA

Description The ROS1 gene is highly conserved from drosophila through zebrafish, rat, cow, rhesus, and homo sapiens. Refseq NM_002944.

Protein

Description ROS1 gene encodes a 2,347 amino acid protein with a molecular weight of 263,915 Daltons (NCBI: P08922). This protein is a type I single pass integral membrane protein with tyrosine kinase activity. SwissProt identifier P08922, Protein NP_002935
Expression ROS1 expression is involved in regionalization of the proximal epididymal epithelium. Expression levels have been highest in liver, platelelts, T-cells and monocytes, but is found across nearly all cell types.
Localisation ROS1 is localized to the cell plasma membrane and contains both extracellular and intracellular domains.
Function ROS1 functions as an orphan receptor tyrosine kinase with an unestablished ligand. ROS1 directly interacts via an SH2 1 domain with PTPN6 which drives ROS1 dephosphorylation (Charest et al., 2006). ROS1 has also been suggested to interact with PTPN11 leading to PI3K/mTOR signaling, and to mediate phosphorylation of VAV3 (Charest et al., 2006). The ligand for wild type ROS1 is unknown and the normal function remains unclear despite the above associations.
Homology ROS1 shares significant homology with other members of the insulin growth factor receptor family, and the gene is highly conserved back through drosophila melanogaster.

Mutations

Germinal None established.
Somatic The intrachromosomal del(6)(q21q22) deletion has been identified in glioblastoma multiforme and leads to the formation of a constitutive active GOPC-ROS1 protein (Charest et al., 2003). In non-small cell lung cancer (NSCLC) the SLC34A2-ROS1 chimeric protein also holds kinase activity. A CD74-ROS1 chimeric protein has also been identified in NSCLC (Awad et al., 2013).

Implicated in

Note
  
Entity Non-small cell lung cancer, renal oncocytoma, gastric cancer, glioblastoma multiforme, cholangiocarcinoma colorectal cancer.
Note There has been a rapidly expanding appreciation of ROS1 fusion proteins in the tumorigenesis of multiple malignancies as discussed below (Charest et. al., 2003, Gu et al., 2011, Rimkunas et al., 2012, Takeuchi et al.,2012, Awad et al., 2013, Lee et al., 2013).
Disease ROS1 rearrangements occur in <2% of NSCLC and are enriched for in adenocarcinoma and young never smokers (Bergethon et al., 2012).
Prognosis To date ROS1 has not been clearly implicated as an independent prognostic variable. ROS1 rearrangements may predict sensitivity to the ALK-inhibitor Crizotinib in NSCLC. Small molecule inhibitor screens have also identified foretinib as a potent inhibitor of multiple ROS1 fusion proteins. Additionaly, ROS1 mutation has been observed as a acquired resistance mechanism to crizotinib. Davare and colleagues have shown that foretinib is capable of inhibiting the G2032R ROS1 mutant which is resistant to crizotinib (Davare et al., 2013).
Cytogenetics ROS1 rearrangements have been documented with the following fusion partners; CCDC6, CD74, CEP85L, also called C6orf204, CLTC, EZR, GOPC, KDELR2, LRIG3, SDC4, SLC34A2, and TPM3.
Translocations and fusion proteins: t(1;6)(q21;q22) TPM3/ROS1; t(4;6)(p15;q22) SLC34A2/ROS1; t(5;6)(q33;q22) CD74/ROS1; t(6;6)(q22;q22) GOPC/ROS1; t(6;6)(q22;q22) CEP85L/ROS1; t(6;6)(q22;q25) EZR/ROS1; t(6;7)(q22;p22) KDELR2/ROS1; t(6;10)(q22;q21) CCDC6/ROS1; t(6;12)(q22;q14) LRIG3/ROS1; t(6;17)(q22;q23)CLTC/ROS1; t(6;20)(q22;q12) SDC4/ROS1 (Charest et. Al., 2003, Gu et al., 2011, Rimkunas et al., 2012, Takeuchi et al., 2012, Awad et al., 2013, Lee et al., 2013, Mitelman et al., 2015). Within NSCLC ROS1 rearrangements are non-overlapping with EGFR, KRAS, and ALK genomic alterations (Davies et al., 2012, Awad et al., 2013, Go et al., 2013).
  

Breakpoints

 
Note Within the COSMIC database ROS1 chromosomal rearrangements have been documented with the following fusion partners ; CD74, EZR, GOPC, SDC4, TPM3, SLC34A2, and LRIG3 (COSMIC, accessed 12/2013).

Bibliography

Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer
Mitelman F Johansson B and Mertens F
http://cgap.nci.nih.gov/Chromosomes/Mitelman
 
ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers
Aisner DL, Nguyen TT, Paskulin DD, Le AT, Haney J, Schulte N, Chionh F, Hardingham J, Mariadason J, Tebbutt N, Doebele RC, Weickhardt AJ, Varella-Garcia M
Mol Cancer Res 2014 Jan;12(1):111-8
PMID 24296758
 
Acquired resistance to crizotinib from a mutation in CD74-ROS1
Awad MM, Katayama R, McTigue M, Liu W, Deng YL, Brooun A, Friboulet L, Huang D, Falk MD, Timofeevski S, Wilner KD, Lockerman EL, Khan TM, Mahmood S, Gainor JF, Digumarthy SR, Stone JR, Mino-Kenudson M, Christensen JG, Iafrate AJ, Engelman JA, Shaw AT
N Engl J Med 2013 Jun 20;368(25):2395-401
PMID 23724914
 
ROS1 rearrangements define a unique molecular class of lung cancers
Bergethon K, Shaw AT, Ou SH, Katayama R, Lovly CM, McDonald NT, Massion PP, Siwak-Tapp C, Gonzalez A, Fang R, Mark EJ, Batten JM, Chen H, Wilner KD, Kwak EL, Clark JW, Carbone DP, Ji H, Engelman JA, Mino-Kenudson M, Pao W, Iafrate AJ
J Clin Oncol 2012 Mar 10;30(8):863-70
PMID 22215748
 
Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)
Charest A, Lane K, McMahon K, Park J, Preisinger E, Conroy H, Housman D
Genes Chromosomes Cancer 2003 May;37(1):58-71
PMID 12661006
 
ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice
Charest A, Wilker EW, McLaughlin ME, Lane K, Gowda R, Coven S, McMahon K, Kovach S, Feng Y, Yaffe MB, Jacks T, Housman D
Cancer Res 2006 Aug 1;66(15):7473-81
PMID 16885344
 
Targeting ROS1 with anaplastic lymphoma kinase inhibitors: a promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer
Chin LP, Soo RA, Soong R, Ou SH
J Thorac Oncol 2012 Nov;7(11):1625-30
PMID 23070242
 
Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia
Cilloni D, Carturan S, Bracco E, Campia V, Rosso V, Torti D, Calabrese C, Gaidano V, Niparuck P, Favole A, Signorino E, Iacobucci I, Morano A, De Luca L, Musto P, Frassoni F, Saglio G
Leuk Res 2013 May;37(5):520-30
PMID 23415111
 
Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins
Davare MA, Saborowski A, Eide CA, Tognon C, Smith RL, Elferich J, Agarwal A, Tyner JW, Shinde UP, Lowe SW, Druker BJ
Proc Natl Acad Sci U S A 2013 Nov 26;110(48):19519-24
PMID 24218589
 
Molecular pathways: ROS1 fusion proteins in cancer
Davies KD, Doebele RC
Clin Cancer Res 2013 Aug 1;19(15):4040-5
PMID 23719267
 
Identifying and targeting ROS1 gene fusions in non-small cell lung cancer
Davies KD, Le AT, Theodoro MF, Skokan MC, Aisner DL, Berge EM, Terracciano LM, Cappuzzo F, Incarbone M, Roncalli M, Alloisio M, Santoro A, Camidge DR, Varella-Garcia M, Doebele RC
Clin Cancer Res 2012 Sep 1;18(17):4570-9
PMID 22919003
 
Novel targets in non-small cell lung cancer: ROS1 and RET fusions
Gainor JF, Shaw AT
Oncologist 2013;18(7):865-75
PMID 23814043
 
Clinicopathologic analysis of ROS1-rearranged non-small-cell lung cancer and proposal of a diagnostic algorithm
Go H, Kim DW, Kim D, Keam B, Kim TM, Lee SH, Heo DS, Bang YJ, Chung DH
J Thorac Oncol 2013 Nov;8(11):1445-50
PMID 24128715
 
Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma
Gu TL, Deng X, Huang F, Tucker M, Crosby K, Rimkunas V, Wang Y, Deng G, Zhu L, Tan Z, Hu Y, Wu C, Nardone J, MacNeill J, Ren J, Reeves C, Innocenti G, Norris B, Yuan J, Yu J, Haack H, Shen B, Peng C, Li H, Zhou X, Liu X, Rush J, Comb MJ
PLoS One 2011 Jan 6;6(1):e15640
PMID 21253578
 
Identification of ROS1 rearrangement in gastric adenocarcinoma
Lee J, Lee SE, Kang SY, Do IG, Lee S, Ha SY, Cho J, Kang WK, Jang J, Ou SH, Kim KM
Cancer 2013 May 1;119(9):1627-35
PMID 23400546
 
Efficacy and safety of crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC).
Ou S, Bang Y, Camidge D, et al.
ASCO Meeting Abstracts 2013;31:8032
 
ROS1 as a 'druggable' receptor tyrosine kinase: lessons learned from inhibiting the ALK pathway
Ou SH, Tan J, Yen Y, Soo RA
Expert Rev Anticancer Ther 2012 Apr;12(4):447-56
PMID 22500682
 
Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion
Rimkunas VM, Crosby KE, Li D, Hu Y, Kelly ME, Gu TL, Mack JS, Silver MR, Zhou X, Haack H
Clin Cancer Res 2012 Aug 15;18(16):4449-57
PMID 22661537
 
RET, ROS1 and ALK fusions in lung cancer
Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, Hatano S, Asaka R, Hamanaka W, Ninomiya H, Uehara H, Lim Choi Y, Satoh Y, Okumura S, Nakagawa K, Mano H, Ishikawa Y
Nat Med 2012 Feb 12;18(3):378-81
PMID 22327623
 
Preclinical rationale for use of the clinically available multitargeted tyrosine kinase inhibitor crizotinib in ROS1-translocated lung cancer
Yasuda H, de Figueiredo-Pontes LL, Kobayashi S, Costa DB
J Thorac Oncol 2012 Jul;7(7):1086-90
PMID 22617245
 

Citation

This paper should be referenced as such :
Samuel J Klempner, Sai-Hong Ou
ROS1 (ROS proto-oncogene 1 , receptor tyrosine kinase)
Atlas Genet Cytogenet Oncol Haematol. 2015;19(5):337-339.
Free journal version : [ pdf ]   [ DOI ]
On line version : http://AtlasGeneticsOncology.org/Genes/ROS1ID42144ch6q22.html

Other Leukemias implicated (Data extracted from papers in the Atlas)

Leukemias TL_t0610q22q24ID1720 TL_t0612q22q24ID1765

Other Solid tumors implicated (Data extracted from papers in the Atlas) [ 30 ]

Solid Tumors t0612q22q14inLungID6496 TranslocLungAdenocarcID6751 TranslocLungSquamCellCarcID6819 TT_inv06q22q25ID6785 TT_t0106q21q22ID6761
TT_t0306q12q22ID106148 TT_t0306q12q22ID106149 TT_t0306q12q22ID106150 TT_t0406p15q22ID6776 TT_t0406p15q22ID6895
TT_t0506q33q22ID106793 TT_t0506q33q22ID6780 TT_t0506q33q22ID6902 TT_t0606p22q22ID107165 TT_t0606q22q22ID107245
TT_t0606q22q22ID107246 TT_t0606q22q22ID107254 TT_t0606q22q22ID6783 TT_t0607q22p22ID6787 TT_t0610q22q21ID6788
TT_t0610q22q25ID106855 TT_t0612q22p11ID106903 TT_t0612q22p13ID106904 TT_t0612q22q24ID106905 TT_t0612q22q24ID106906
TT_t0612q22q24ID106907 TT_t0615q22q21ID106942 TT_t0617q22p13ID106972 TT_t0617q22q23ID106974 TT_t0620q22q12ID6790

External links

Nomenclature
HGNC (Hugo)ROS1   10261
LRG (Locus Reference Genomic)LRG_997
Cards
AtlasROS1ID42144ch6q22
Entrez_Gene (NCBI)ROS1  6098  ROS proto-oncogene 1, receptor tyrosine kinase
AliasesMCF3; ROS; c-ros-1
GeneCards (Weizmann)ROS1
Ensembl hg19 (Hinxton)ENSG00000047936 [Gene_View]
Ensembl hg38 (Hinxton)ENSG00000047936 [Gene_View]  ENSG00000047936 [Sequence]  chr6:117288367-117425855 [Contig_View]  ROS1 [Vega]
ICGC DataPortalENSG00000047936
TCGA cBioPortalROS1
AceView (NCBI)ROS1
Genatlas (Paris)ROS1
WikiGenes6098
SOURCE (Princeton)ROS1
Genetics Home Reference (NIH)ROS1
Genomic and cartography
GoldenPath hg38 (UCSC)ROS1  -     chr6:117288367-117425855 -  6q22.1   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)ROS1  -     6q22.1   [Description]    (hg19-Feb_2009)
GoldenPathROS1 - 6q22.1 [CytoView hg19]  ROS1 - 6q22.1 [CytoView hg38]
ImmunoBaseENSG00000047936
Mapping of homologs : NCBIROS1 [Mapview hg19]  ROS1 [Mapview hg38]
OMIM165020   
Gene and transcription
Genbank (Entrez)BC144556 LC119066 LC119067 LC119068 LC119069
RefSeq transcript (Entrez)NM_002944
RefSeq genomic (Entrez)
Consensus coding sequences : CCDS (NCBI)ROS1
Cluster EST : UnigeneHs.1041 [ NCBI ]
CGAP (NCI)Hs.1041
Alternative Splicing GalleryENSG00000047936
Gene ExpressionROS1 [ NCBI-GEO ]   ROS1 [ EBI - ARRAY_EXPRESS ]   ROS1 [ SEEK ]   ROS1 [ MEM ]
Gene Expression Viewer (FireBrowse)ROS1 [ Firebrowse - Broad ]
SOURCE (Princeton)Expression in : [Datasets]   [Normal Tissue Atlas]  [carcinoma Classsification]  [NCI60]
GenevestigatorExpression in : [tissues]  [cell-lines]  [cancer]  [perturbations]  
BioGPS (Tissue expression)6098
GTEX Portal (Tissue expression)ROS1
Human Protein AtlasENSG00000047936-ROS1 [pathology]   [cell]   [tissue]
Protein : pattern, domain, 3D structure
UniProt/SwissProtP08922   [function]  [subcellular_location]  [family_and_domains]  [pathology_and_biotech]  [ptm_processing]  [expression]  [interaction]
NextProtP08922  [Sequence]  [Exons]  [Medical]  [Publications]
With graphics : InterProP08922
Splice isoforms : SwissVarP08922
PhosPhoSitePlusP08922
Domaine pattern : Prosite (Expaxy)FN3 (PS50853)    PROTEIN_KINASE_ATP (PS00107)    PROTEIN_KINASE_DOM (PS50011)    PROTEIN_KINASE_TYR (PS00109)    RECEPTOR_TYR_KIN_II (PS00239)   
Domains : Interpro (EBI)6-blade_b-propeller_TolB-like    FN3_dom    FN3_sf    Ig-like_fold    Kinase-like_dom_sf    LDLR_classB_rpt    Prot_kinase_dom    Protein_kinase_ATP_BS    Ser-Thr/Tyr_kinase_cat_dom    Tyr_kinase_AS    Tyr_kinase_cat_dom    Tyr_kinase_rcpt_2_CS   
Domain families : Pfam (Sanger)fn3 (PF00041)    Pkinase_Tyr (PF07714)   
Domain families : Pfam (NCBI)pfam00041    pfam07714   
Domain families : Smart (EMBL)FN3 (SM00060)  LY (SM00135)  TyrKc (SM00219)  
Conserved Domain (NCBI)ROS1
DMDM Disease mutations6098
Blocks (Seattle)ROS1
PDB (RSDB)3ZBF    4UXL   
PDB Europe3ZBF    4UXL   
PDB (PDBSum)3ZBF    4UXL   
PDB (IMB)3ZBF    4UXL   
Structural Biology KnowledgeBase3ZBF    4UXL   
SCOP (Structural Classification of Proteins)3ZBF    4UXL   
CATH (Classification of proteins structures)3ZBF    4UXL   
SuperfamilyP08922
Human Protein Atlas [tissue]ENSG00000047936-ROS1 [tissue]
Peptide AtlasP08922
HPRD01295
IPIIPI00288965   IPI00647703   IPI00647258   
Protein Interaction databases
DIP (DOE-UCLA)P08922
IntAct (EBI)P08922
FunCoupENSG00000047936
BioGRIDROS1
STRING (EMBL)ROS1
ZODIACROS1
Ontologies - Pathways
QuickGOP08922
Ontology : AmiGOregulation of cell growth  columnar/cuboidal epithelial cell development  protein tyrosine kinase activity  transmembrane receptor protein tyrosine kinase activity  protein binding  ATP binding  integral component of plasma membrane  protein phosphorylation  transmembrane receptor protein tyrosine kinase signaling pathway  spermatogenesis  cell proliferation  cell surface  negative regulation of gene expression  regulation of phosphate transport  membrane  protein phosphatase binding  signal transduction by protein phosphorylation  cell differentiation  regulation of TOR signaling  regulation of TOR signaling  peptidyl-tyrosine autophosphorylation  receptor complex  perinuclear region of cytoplasm  regulation of ERK1 and ERK2 cascade  
Ontology : EGO-EBIregulation of cell growth  columnar/cuboidal epithelial cell development  protein tyrosine kinase activity  transmembrane receptor protein tyrosine kinase activity  protein binding  ATP binding  integral component of plasma membrane  protein phosphorylation  transmembrane receptor protein tyrosine kinase signaling pathway  spermatogenesis  cell proliferation  cell surface  negative regulation of gene expression  regulation of phosphate transport  membrane  protein phosphatase binding  signal transduction by protein phosphorylation  cell differentiation  regulation of TOR signaling  regulation of TOR signaling  peptidyl-tyrosine autophosphorylation  receptor complex  perinuclear region of cytoplasm  regulation of ERK1 and ERK2 cascade  
NDEx NetworkROS1
Atlas of Cancer Signalling NetworkROS1
Wikipedia pathwaysROS1
Orthology - Evolution
OrthoDB6098
GeneTree (enSembl)ENSG00000047936
Phylogenetic Trees/Animal Genes : TreeFamROS1
HOGENOMP08922
Homologs : HomoloGeneROS1
Homology/Alignments : Family Browser (UCSC)ROS1
Gene fusions - Rearrangements
Fusion : MitelmanCCDC6/ROS1 [10q21.2/6q22.1]  [t(6;10)(q22;q21)]  
Fusion : MitelmanCD74/ROS1 [5q32/6q22.1]  [t(5;6)(q33;q22)]  
Fusion : MitelmanCEP85L/ROS1 [6q22.31/6q22.1]  [t(6;6)(q22;q22)]  
Fusion : MitelmanCLTC/ROS1 [17q23.1/6q22.1]  [t(6;17)(q22;q23)]  
Fusion : MitelmanEZR/ROS1 [6q25.3/6q22.1]  [inv(6)(q22q25)]  [t(6;6)(q22;q25)]  
Fusion : MitelmanGOPC/ROS1 [6q22.1/6q22.1]  [del(6)(q22)]  [del(6)(q22q22)]  
[t(6;6)(q22;q22)]  
Fusion : MitelmanKDELR2/ROS1 [7p22.1/6q22.1]  [t(6;7)(q22;p22)]  
Fusion : MitelmanKMT2A/ROS1 [11q23.3/6q22.1]  [t(6;6)(q22;q22)]  
Fusion : MitelmanLRIG3/ROS1 [12q14.1/6q22.1]  [t(6;12)(q22;q14)]  
Fusion : MitelmanROS1/CD74 [6q22.1/5q32]  [t(5;6)(q33;q22)]  
Fusion : MitelmanSDC4/ROS1 [20q13.12/6q22.1]  [t(6;20)(q22;q12)]  
Fusion : MitelmanSLC34A2/ROS1 [4p15.2/6q22.1]  [t(4;6)(p15;q22)]  
Fusion : MitelmanTFG/ROS1 [3q12.2/6q22.1]  [t(3;6)(q12;q22)]  
Fusion : MitelmanTPM3/ROS1 [1q21.3/6q22.1]  [t(1;6)(q21;q22)]  
Fusion : MitelmanYWHAE/ROS1 [17p13.3/6q22.1]  [t(6;17)(q22;p13)]  
Fusion : COSMICCD74 [5q33.1]  -  ROS1 [6q22.1]  [fusion_1200]  [fusion_1201]  [fusion_1202]  [fusion_1203]  [fusion_1478]  [fusion_1619]  
Fusion : COSMICCLIP1 [12q24.31]  -  ROS1 [6q22.1]  [fusion_1643]  [fusion_1644]  
Fusion : COSMICERC1 [12p13.33]  -  ROS1 [6q22.1]  [fusion_1627]  [fusion_1628]  
Fusion : COSMICEZR [6q25.3]  -  ROS1 [6q22.1]  [fusion_1267]  [fusion_1268]  
Fusion : COSMICGOPC [6q22.1]  -  ROS1 [6q22.1]  [fusion_1139]  [fusion_1140]  [fusion_1188]  [fusion_1210]  [fusion_1243]  [fusion_1251]  [fusion_1295]  
Fusion : COSMICHLA-A [6p22.1]  -  ROS1 [6q22.1]  [fusion_1637]  [fusion_1638]  
Fusion : COSMICKIAA1598 [ROS1]  -  6q22.1 [1647]  [fusion_1648]  
Fusion : COSMICLRIG3 [12q14.1]  -  ROS1 [6q22.1]  [fusion_1269]  [fusion_1270]  
Fusion : COSMICMYO5A [15q21.2]  -  ROS1 [6q22.1]  [fusion_1639]  [fusion_1640]  
Fusion : COSMICPPFIBP1 [12p11.23]  -  ROS1 [6q22.1]  [fusion_1631]  [fusion_1632]  
Fusion : COSMICPWWP2A [5q33.3]  -  ROS1 [6q22.1]  [fusion_1641]  [fusion_1642]  
Fusion : COSMICSDC4 [20q13.12]  -  ROS1 [6q22.1]  [fusion_1265]  [fusion_1266]  [fusion_1278]  [fusion_1279]  [fusion_1280]  [fusion_1671]  [fusion_1672]  
[fusion_1673]  
Fusion : COSMICSLC34A2 [4p15.2]  -  ROS1 [6q22.1]  [fusion_1196]  [fusion_1197]  [fusion_1198]  [fusion_1259]  [fusion_1260]  [fusion_1261]  [fusion_1618]  
Fusion : COSMICTPM3 [1q21.3]  -  ROS1 [6q22.1]  [fusion_1273]  [fusion_1274]  [fusion_1663]  [fusion_1664]  
Fusion : COSMICZCCHC8 [12q24.31]  -  ROS1 [6q22.1]  [fusion_1645]  [fusion_1646]  
Fusion PortalC6orf204 ROS1 6q22.1 GBM
Fusion PortalCLTC 17q23.1 ROS1 6q22.1 LUAD
Fusion PortalEZR 6q25.3 ROS1 6q22.1 LUAD
Fusion : TICdbCD74 [5q32]  -  ROS1 [6q22.1]
Fusion : TICdbGOPC [6q22.1]  -  ROS1 [6q22.1]
Fusion : TICdbSLC34A2 [4p15.2]  -  ROS1 [6q22.1]
Fusion Cancer (Beijing)CCDC6 [10q21.2]  -  ROS1 [6q22.1]  [FUSC002622]  [FUSC002622]
Fusion Cancer (Beijing)CD74 [5q32]  -  ROS1 [6q22.1]  [FUSC003425]  [FUSC003425]
Fusion Cancer (Beijing)ROS1 [6q22.1]  -  CCDC6 [10q21.2]  [FUSC002665]  [FUSC002665]
Fusion Cancer (Beijing)SLC34A2 [4p15.2]  -  ROS1 [6q22.1]  [FUSC003670]  [FUSC003670]
Fusion : FusionGDB12381    31724    31725    31726    34340    6259    6843    7543   
Fusion : Fusion_HubALK--ROS1    C6ORF204--ROS1    CCDC6--ROS1    CD74--ROS1    CD74_ENST00000009530--ROS1    CEP85L--ROS1    CLIP1--ROS1    CLTC--ROS1    ERC1--ROS1    EZR--ROS1    FIG--ROS1    GOLGB1--ROS1    GOPC--ROS1    HLA-A--ROS1    KDELR2--ROS1   
KIAA1598--ROS1    KRTAP16-1--ROS1    LRIG3--ROS1    MCM9--ROS1    MET--ROS1    MSN--ROS1    MYO5A--ROS1    PPFIBP1--ROS1    PWWP2A--ROS1    ROS1--ALK    ROS1--CCDC6    ROS1--CD74    ROS1--CEP85L    ROS1--CLTC    ROS1--EZR   
ROS1--FIG    ROS1--GOPC    ROS1--MET    ROS1--MSN    ROS1--RET    ROS1--SDC4    ROS1--SLC16A10    ROS1--SLC34A2    ROS1--SLC4A4    ROS1--TFG    ROS1--TPM3    ROS1--TTN    ROS1--ZCCHC8    SDC4--ROS1    SLC34A2--ROS1   
STXBP5--ROS1    TFG--ROS1    TMEM106B--ROS1    TPM3--ROS1    TPM3_ENST00000368530--ROS1    ZCCHC8--ROS1   
Fusion : QuiverROS1
Polymorphisms : SNP and Copy number variants
NCBI Variation ViewerROS1 [hg38]
dbSNP Single Nucleotide Polymorphism (NCBI)ROS1
dbVarROS1
ClinVarROS1
1000_GenomesROS1 
Exome Variant ServerROS1
ExAC (Exome Aggregation Consortium)ENSG00000047936
GNOMAD BrowserENSG00000047936
Varsome BrowserROS1
Genetic variants : HAPMAP6098
Genomic Variants (DGV)ROS1 [DGVbeta]
DECIPHERROS1 [patients]   [syndromes]   [variants]   [genes]  
CONAN: Copy Number AnalysisROS1 
Mutations
ICGC Data PortalROS1 
TCGA Data PortalROS1 
Broad Tumor PortalROS1
OASIS PortalROS1 [ Somatic mutations - Copy number]
Somatic Mutations in Cancer : COSMICROS1  [overview]  [genome browser]  [tissue]  [distribution]  
Somatic Mutations in Cancer : COSMIC3DROS1
Mutations and Diseases : HGMDROS1
LOVD (Leiden Open Variation Database)Whole genome datasets
LOVD (Leiden Open Variation Database)LOVD - Leiden Open Variation Database
LOVD (Leiden Open Variation Database)LOVD 3.0 shared installation
BioMutasearch ROS1
DgiDB (Drug Gene Interaction Database)ROS1
DoCM (Curated mutations)ROS1 (select the gene name)
CIViC (Clinical Interpretations of Variants in Cancer)ROS1 (select a term)
intoGenROS1
NCG5 (London)ROS1
Cancer3DROS1(select the gene name)
Impact of mutations[PolyPhen2] [Provean] [Buck Institute : MutDB] [Mutation Assessor] [Mutanalyser]
Diseases
OMIM165020   
Orphanet
DisGeNETROS1
MedgenROS1
Genetic Testing Registry ROS1
NextProtP08922 [Medical]
TSGene6098
GENETestsROS1
Target ValidationROS1
Huge Navigator ROS1 [HugePedia]
snp3D : Map Gene to Disease6098
BioCentury BCIQROS1
ClinGenROS1
Clinical trials, drugs, therapy
Chemical/Protein Interactions : CTD6098
Chemical/Pharm GKB GenePA34633
Clinical trialROS1
Miscellaneous
canSAR (ICR)ROS1 (select the gene name)
DataMed IndexROS1
Probes
Litterature
PubMed142 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
CoreMineROS1
EVEXROS1
GoPubMedROS1
iHOPROS1
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Mon Aug 26 19:24:44 CEST 2019
Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.